Sicart Associates’s MetLife MET Stock Holding History

Sicart Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,732	Closed	-$323K	–	96
2016 Q4	$323K	Buy	+6,732	New	+$309K	0.22%	85

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sicart Associates's MET Position: Q1 2017 in Review

Sicart Associates sold out of MetLife (MET) in Q1 2017, closing a stake of 6,732 shares — an estimated $323K sold.

Sicart Associates first reported a position in MET in Q4 2016 and held it in 1 quarter. The position peaked at $323K in Q4 2016. 1,046 funds tracked by Wall St. Rank hold MET as of Q1 2017.

Sicart Associates reported no remaining MetLife position as of Q1 2017 after selling out during the quarter.
Sicart Associates sold 6,732 MetLife shares in Q1 2017, an estimated $323K.
Sicart Associates first reported a position in MetLife in Q4 2016 and held it in 1 quarter.
Sicart Associates's MetLife position peaked at $323K in Q4 2016.
1,046 funds tracked by Wall St. Rank held MetLife as of Q1 2017.

Based on Sicart Associates's 13F filing for Q1 2017, filed 10 Apr 2017.